| 1 |
Xian J, Zhong X, Huang Q, Gu H, Feng Y, Sun J, Wang D, Li J, Zhang C, Wu Y, Zhang J. N-Trimethylated chitosan coating WAT vascular-targeting oral nano-system for the enhanced anti-obesity effects of celastrol. Int J Biol Macromol 2023;:124023. [PMID: 36924876 DOI: 10.1016/j.ijbiomac.2023.124023] [Reference Citation Analysis]
|
| 2 |
Zhu L, Wang Y, Jin S, Niu Y, Yu M, Li Z, Chen L, Wu X, Ding C, Wu T, Shi X, Zhang Y, Luo D, Liu Y. Parishin A-loaded mesoporous silica nanoparticles modulate macrophage polarization to attenuate tendinopathy. NPJ Regen Med 2023;8:14. [PMID: 36899012 DOI: 10.1038/s41536-023-00289-0] [Reference Citation Analysis]
|
| 3 |
Kumar G, Virmani T, Sharma A, Pathak K. Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers. Pharmaceutics 2023;15:889. [DOI: 10.3390/pharmaceutics15030889] [Reference Citation Analysis]
|
| 4 |
Dohmen C, Ihmels H. Switching between DNA binding modes with a photo- and redox-active DNA-targeting ligand. Org Biomol Chem 2023;21:1958-66. [PMID: 36762516 DOI: 10.1039/d3ob00013c] [Reference Citation Analysis]
|
| 5 |
Yang R, Wu R, Zhang B, Guo H, Qu J, Xia J, Zhang G, Shen M, Shi X. Gossypol‐Crosslinked Nanoclusters of Ultrasmall Iron Oxide Nanoparticles for Ultrasound‐Enhanced Precision Tumor Theranostics. Advanced Sensor Research 2023. [DOI: 10.1002/adsr.202200089] [Reference Citation Analysis]
|
| 6 |
Xiao G, Xu Z, Luo F. Combinational antitumor strategies of exosomes as drug carriers: Mini review. Front Pharmacol 2022;13:1107329. [PMID: 36744207 DOI: 10.3389/fphar.2022.1107329] [Reference Citation Analysis]
|
| 7 |
Zhou Z, Ke Q, Wu M, Zhang L, Jiang K. Pore Space Partition Approach of ZIF-8 for pH Responsive Codelivery of Ursolic Acid and 5-Fluorouracil. ACS Materials Lett 2023. [DOI: 10.1021/acsmaterialslett.2c01097] [Reference Citation Analysis]
|
| 8 |
Qiao H, Zhang J, Cheng YC. Preface: Phyto-derived nanomedicines for therapeutics, imaging and drug delivery. Adv Drug Deliv Rev 2022;:114668. [PMID: 36503066 DOI: 10.1016/j.addr.2022.114668] [Reference Citation Analysis]
|
| 9 |
Mohamad NA, Rahman AA, Sheikh Abdul Kadir SH. Hydroxychavicol as a potential anticancer agent (Review). Oncol Lett 2023;25:34. [PMID: 36589673 DOI: 10.3892/ol.2022.13620] [Reference Citation Analysis]
|
| 10 |
Lin X, Wang Q, Du S, Guan Y, Qiu J, Chen X, Yuan D, Chen T. Nanoparticles for co-delivery of paclitaxel and curcumin to overcome chemoresistance against breast cancer. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.104050] [Reference Citation Analysis]
|
| 11 |
Naeem A, Hu P, Yang M, Zhang J, Liu Y, Zhu W, Zheng Q. Natural Products as Anticancer Agents: Current Status and Future Perspectives. Molecules 2022;27. [PMID: 36500466 DOI: 10.3390/molecules27238367] [Reference Citation Analysis]
|
| 12 |
Zhou H, Yuan Y, Wang Z, Ren Z, Hu M, Lu J, Gao H, Pan C, Zhao W, Zhu B. Co-delivery of doxorubicin and quercetin by Janus Hollow Silica Nanomotors for overcoming multidrug resistance in breast MCF-7/Adr cells. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2022. [DOI: 10.1016/j.colsurfa.2022.130654] [Reference Citation Analysis]
|
| 13 |
Liu Y, Zhu L, Jin S, Wang Y, Niu Y, Yu M, Li Z, Chen L, Wu X, Ding C, Wu T, Shi X, Zhang Y, Luo D. Parishin A-loaded Mesoporous Silica Nanoparticles Modulate Macrophage Polarization to Attenuate Tendinopathy.. [DOI: 10.21203/rs.3.rs-2111210/v1] [Reference Citation Analysis]
|
| 14 |
Cruz-martins N. Molecular Mechanisms of Anti-Inflammatory Phytochemicals. IJMS 2022;23:11016. [DOI: 10.3390/ijms231911016] [Reference Citation Analysis]
|
| 15 |
Wu J, Qi C, Wang H, Wang Q, Sun J, Dong J, Yu G, Gao Z, Zhang B, Tian G. Curcumin and berberine co-loaded liposomes for anti-hepatocellular carcinoma therapy by blocking the cross-talk between hepatic stellate cells and tumor cells. Front Pharmacol 2022;13:961788. [DOI: 10.3389/fphar.2022.961788] [Reference Citation Analysis]
|
| 16 |
Xiao M, Wu S, Cheng Y, Ma J, Luo X, Chang L, Zhang C, Chen J, Zou L, You Y, Zhang J. Colon-specific delivery of isoliquiritigenin by oral edible zein/caseate nanocomplex for ulcerative colitis treatment. Front Chem 2022;10:981055. [DOI: 10.3389/fchem.2022.981055] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
